Screening
|
Who needs it
|
How often
|
Alcohol misuse
|
All adults
|
At routine exams
|
Blood pressure
|
All adults
|
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends the following screening schedules:
-
Every 2 years if blood pressure reading < 120/80 mm Hg, or
-
Yearly if systolic blood pressure reading of 120 to 139 mm Hg or diastolic blood pressure reading of 80 to 89 mm Hg
|
Breast cancer
|
Women ages 20 years and older*
Women under the age of 20, talk with your health care provider and make an informed decision about performing monthly breast self-exams based on your family history, current medical condition, and personal values
|
Clinical breast exam every 3 years*
|
Cervical cancer
|
Women ages 21 and older
|
According to the American Cancer Society (ACS), all women should have Pap tests starting at age 21. Women between ages 21 and 29 should have a Pap test every 3 years. Women between the ages of 30 and 65 should have a Pap test plus an HPV test (called "co-testing") every 5 years. This is the preferred approach, but it is also acceptable to continue to have Pap tests alone every 3 years. A woman who has had a hysterectomy (with removal of the cervix) for reasons not related to cervical cancer and who has no history of cervical cancer or serious precancer should not be screened. A woman who has been vaccinated against HPV should still follow the screening recommendations for her age group.
|
Chlamydia
|
Sexually active women ages 24 and younger, and women at increased risk for infection
|
Every 3 years if at risk or if you have symptoms
|
Depression
|
All adults in clinical practices that have staff and systems in place to assure accurate diagnosis, effective treatment, and follow-up
|
At routine exams
|
Diabetes mellitus, type 2
|
Adults with no symptoms who have sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg
|
At least every 3 years
|
Gonorrhea
|
Sexually active women at increased risk for infection
|
At routine exams
|
HIV
|
Anyone at increased risk for infection
|
At routine checkups
|
Obesity
|
All adults
|
At routine checkups
|
Syphilis
|
Women at increased risk for infection
|
At routine exams if at risk
|
Tuberculosis
|
Anyone at increased risk for infection
|
Check with your health care provider
|
Vision
|
All adults1
|
At least one comprehensive exam in your 20s, and two in your 30s
|
Counseling
|
Who needs it
|
How often
|
Breast cancer, chemoprevention
|
Women at high risk
|
When risk is identified
|
BRCA mutation testing for breast and ovarian cancer susceptibility
|
Women with increased risk
|
When risk is identified
|
Diet, behavioral counseling
|
Adults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease
|
When diagnosed
|
Tobacco use and tobacco-related disease
|
All adults
|
Every visit
|
Immunization
|
Who needs it
|
How often
|
Human papillomavirus (HPV)
|
Recommended for all females ages 11 to 26
|
Three doses
The second dose should be given 1 to 2 months after the first dose, and the third dose should be given 6 months after the first dose
|
Tetanus/diphtheria/pertussis (Td/Tdap) booster
|
All adults
|
Td: every 10 years
Tdap: substitute a one-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years
|
Chickenpox (varicella)
|
All adults ages 19 to 49 who have no documentation of previous infection or vaccinations
|
Two doses; the second dose should be given 4 to 8 weeks after the first dose
|
Measles, mumps, rubella (MMR) vaccine
|
All adults ages 19 to 49 who have no documentation of previous infection or vaccinations
|
One or two doses
|
Flu vaccine (seasonal)
|
All adults
|
Yearly
|
Hepatitis A vaccine
|
People at risk2
|
Two doses given at least 6 months apart
|
Hepatitis B vaccine
|
People at risk3
|
Three doses; second dose should be given 1 month after the first dose; the third dose should be given at least 2 months after the second dose (and at least 4 months after the first dose)
|
Meningococcal
|
People at risk4
|
One or more doses
|
Pneumococcal (polysaccharide)
|
People at risk5
|
One or two doses
|